Intended for healthcare professionals

Letters Chemotherapy in terminal cancer

Treatment decisions in end stage cancer

BMJ 2011; 342 doi: (Published 10 May 2011) Cite this as: BMJ 2011;342:d2720
  1. Jan Schildmann, research fellow1,
  2. Jochen Vollmann, director1
  1. 1Institute for Medical Ethics and History of Medicine, Ruhr-University Bochum, 44799 Bochum, Germany
  1. jan.schildmann{at}

Buiting and colleagues’ study suggests that medical oncologists’ treatment decisions in end stage cancer are based mostly on rational considerations regarding (side) effects.1 This contrasts with the findings of our qualitative interview study …

View Full Text

Log in

Log in through your institution


* For online subscription